Abstract

Nemo-like kinase (NLK), a mediator of the Wnt signaling pathway, binds directly to c-Myb, leading to its phosphorylation, ubiquitination and proteasome-dependent degradation. NLK was significantly downregulated in the breast cancer tissues compared to corresponding normal tissues. NLK expression was negatively correlated with c-Myb expression. NLK suppressed proliferation, induced apoptosis and mediated c-Myb degradation in MCF-7 cells via a mechanism that seems to involve c-myc and Bcl2. These findings might provide a novel target for therapeutic intervention in patients with breast cancer.

Highlights

  • Breast cancer is one of the most debilitating human carcinomas and has the second highest mortality rate after lung cancer in women [1]

  • It is known that most breast carcinomas occur as a result of alterations in oncogenes and tumor suppressor genes, which regulate the signal transduction pathways involved in cell proliferation, differentiation and apoptosis

  • Aberrant expression of Nemo-like kinase (NLK) was correlated with proliferation and apoptosis in hepatocellular carcinoma [3], prostate cancer

Read more

Summary

Introduction

Breast cancer is one of the most debilitating human carcinomas and has the second highest mortality rate after lung cancer in women [1]. There is a very large body of information on the development and progression of breast cancer, all key factors have not yet been elucidated. Wnt proteins belong to a large family of secreted signaling molecules that direct cell growth and fate [2]. Several lines of recent evidence show that the Wnt pathway is critical for the development of a normal mammary gland, whereas aberrant Wnt signaling is observed in cancer [1]. The Nemo-like kinase (NLK) of the Wnt signaling pathway is a member of the extracellular-signal regulated kinase/microtubule-associated protein kinase MAPK) and cyclin-dependent kinase (Cdk) families [3]. NLK functions downstream of transforming growth factor b-activated kinase (TAK1), which is a member of the mitogen-activated protein kinase kinase kinase (MAPKKK or MAP3K) family [4]

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call